In line with this report, diabetes-induced retinal expression of galectin-1 can also be suppressed via treatment with anti-inflammatory glucocorticoids in mice, through the modulation of AKT, ERK 1/2 and AP-1 phosphorylation [99]. The gene discussed is LGALS1; the disease is diabetes mellitus.